Amanuel Negussie DOS 772 Citation Assignment August 4, 2013 References 1. Koga DH, Salvajoli JV, Alves FA.

. Dental extractions and radiotherapy in head and neck oncology: review of the literature. Oral Dis. 2008;14:40-44. 2. Dogan N, King S, Emami B, et al. Assessment of different IMRT boost delivery methods on target coverage and normal-tissue sparing. Int J Radiat Oncol Biol Phys. 2003;57(5):1480-1491. 3. Bhide SA, Newbold KL, Harrington KJ, et al. Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers. Br J Radiol. 2012;85:487-494. 4. Teoh M, Beveridge S, Wood K, et al. Volumetric-modulated arc therapy (RapidArc)vs. conventional fixed field intensity modulated radiotherapy for F-FDG-PET-guided dose escalation in oropharyngeal cancer: A planning study. Med Dos. 2013;38:18-24. 5. Verdonck HWD, De Jong JMA, Granzier MEPG, et al. Intensity-modulated radiation therapy for oropharyngeal cancer: Radiation dosage constraint at anterior mandible. Radiat Oncol. 2009;45:511-514. 6. Claus F, Duthoy W, Boterberg T, et al. Intensity modulated radiation therapy for oropharyngeal and oral cavity tumors: clinical use and experience. Oral Oncol. 2002;38:597-604. 7. Hong AM, Dobbins TA, Lee CS, et al. Human papilloma virus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy. Br J Cancer. 2010;103:1510-1517. 8. Arruda FF, Puri DR, Zhung J, et al. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: The Memorial Sloan_Kettering Cancer Center experience. Int J Radiat Oncol Biol Phy. 2006;64(2):363-373. 9. Hong TS, Tome WA, Harari PM. Heterogeneity in head and neck IMRT target design and clinical practice. Radiother Oncol. 2012;103:92-98. 10. Machtay M. A phase III study of postoperative radiationtherapy (IMRT)+/- Cetuximab for locally advanced resected head and neck cancer.

http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0920. 2013. Accessed August 1, 2013.